278 related articles for article (PubMed ID: 14668771)
21. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction.
Cuocolo A; Acampa W; Nicolai E; Pace L; Petretta M; Salvatore M
J Nucl Cardiol; 2000; 7(1):8-15. PubMed ID: 10698229
[TBL] [Abstract][Full Text] [Related]
22. Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction: comparison with two-dimensional echocardiography.
Leoncini M; Marcucci G; Sciagrà R; Frascarelli F; Traini AM; Mondanelli D; Magni M; Bini L; Bellandi F; Mennuti A; Dabizzi RP
J Nucl Cardiol; 2000; 7(5):426-31. PubMed ID: 11083190
[TBL] [Abstract][Full Text] [Related]
23. Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.
Slart RH; Bax JJ; Sluiter WJ; van Veldhuisen DJ; Jager PL
J Nucl Cardiol; 2004; 11(6):689-96. PubMed ID: 15592192
[TBL] [Abstract][Full Text] [Related]
24. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
[TBL] [Abstract][Full Text] [Related]
25. The influence of nitroglycerin on myocardial 99mTc-Tetrofosmin uptake defects in coronary artery disease.
Tarkowska A; Cholewiński W; Widomska-Czekajska T; Stefaniak B; Poniatowicz-Frasunek E; Wypych M; Chrapko B
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):254-68. PubMed ID: 12898848
[TBL] [Abstract][Full Text] [Related]
26. [Head to head comparison of dobutamine alone and combined with nitrate stress echocardiography and 99mTc-MIBI/18FDG myocardial SPECT image for diagnosis of viable myocardium in patients with severe left ventricular dysfunction].
Yang YJ; Yang WX; Shi RF; Hu FH; You SJ; Tian YQ; He ZX; Wang YW; Ye L; Chen JL; Gao RL; Chen ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):323-7. PubMed ID: 15932661
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
[TBL] [Abstract][Full Text] [Related]
28. Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT.
Mabuchi M; Kubo N; Morita K; Makino Y; Matsui Y; Murashita T; Yasuda K; Tsukamoto E; Tamaki N
Nucl Med Commun; 2003 Jun; 24(6):625-31. PubMed ID: 12766597
[TBL] [Abstract][Full Text] [Related]
29. Myocardial viability assessment with gated SPECT Tc-99m tetrofosmin % wall thickening: comparison with F-18 FDG-PET.
Maruyama A; Hasegawa S; Paul AK; Xiuli M; Yoshioka J; Maruyama K; Hori M; Nishimura T
Ann Nucl Med; 2002 Feb; 16(1):25-32. PubMed ID: 11922205
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.
Schinkel AF; Bax JJ; Sozzi FB; Boersma E; Valkema R; Elhendy A; Roelandt JR; Poldermans D
Heart; 2002 Aug; 88(2):125-30. PubMed ID: 12117829
[TBL] [Abstract][Full Text] [Related]
31. Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose.
Matsunari I; Böning G; Ziegler SI; Nekolla SG; Stollfuss JC; Kosa I; Ficaro EP; Schwaiger M
J Am Coll Cardiol; 1998 Oct; 32(4):927-35. PubMed ID: 9768713
[TBL] [Abstract][Full Text] [Related]
32. [Improved detection of fill-in using sublingual nitroglycerin in technetium-99m tetrofosmin exercise/rest single photon emission computed tomography one day protocol for old myocardial infarction].
Miyanaga H; Kunieda Y; Oguni A; Kamitani T; Kawasaki S; Takahashi T
J Cardiol; 1999 Mar; 33(3):135-43. PubMed ID: 10225193
[TBL] [Abstract][Full Text] [Related]
33. Reverse redistribution phenomenon on rest (99m)Tc-tetrofosmin myocardial single photon emission computed tomography involves impaired left ventricular contraction in patients with acute myocardial infarction.
Kurokawa K; Ohte N; Miyabe H; Akita S; Yajima K; Hayano J; Kimura G
Circ J; 2003 Oct; 67(10):830-4. PubMed ID: 14578614
[TBL] [Abstract][Full Text] [Related]
34. Adenosine Tc-99m tetrofosmin SPECT in differentiation of ischemic from nonischemic cardiomyopathy in patients with LV systolic dysfunction.
Her SH; Yoon HJ; Lee JM; Jin SW; Youn HJ; Seung KB; Kim JH
Clin Nucl Med; 2008 Jul; 33(7):459-63. PubMed ID: 18580229
[TBL] [Abstract][Full Text] [Related]
35. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
Kühl HP; Beek AM; van der Weerdt AP; Hofman MB; Visser CA; Lammertsma AA; Heussen N; Visser FC; van Rossum AC
J Am Coll Cardiol; 2003 Apr; 41(8):1341-8. PubMed ID: 12706930
[TBL] [Abstract][Full Text] [Related]
36. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
[TBL] [Abstract][Full Text] [Related]
37. Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
Feola M; Biggi A; Francini A; Leonardi G; Vado A; Ribichini F; Uslenghi E
Arch Med Res; 2006 Jan; 37(1):117-22. PubMed ID: 16314196
[TBL] [Abstract][Full Text] [Related]
38. Assessment of myocardial viability in dysfunctional myocardium by resting myocardial blood flow determined with oxygen 15 water PET.
Nowak B; Schaefer WM; Koch KC; Kaiser HJ; Block S; Knackstedt C; Zimny M; vom Dahl J; Buell U
J Nucl Cardiol; 2003; 10(1):34-45. PubMed ID: 12569329
[TBL] [Abstract][Full Text] [Related]
39. Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.
Roes SD; Kaandorp TA; Marsan NA; Westenberg JJ; Dibbets-Schneider P; Stokkel MP; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):594-601. PubMed ID: 19050879
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
